Deutsche Bank Ag\ Alector, Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

A detailed history of Deutsche Bank Ag\ transactions in Alector, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 2,642,867 shares of ALEC stock, worth $12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,642,867

Previous 2,062,099 28.16%

Holding current value

$12 Million

Previous $16.5 Million 3.31%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.69 - $8.08 $3.3 Million - $4.69 Million	580,768 Added 28.16%	2,642,867 $15.9 Million
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $7.65 Million - $17 Million	2,028,862 Added 6104.23%	2,062,099 $16.5 Million
Q3 2023 Nov 09, 2023	SELL	$5.2 - $8.77 $1.29 Million - $2.17 Million	-247,993 Reduced 88.18%	33,237 $215,000
Q2 2023 Aug 14, 2023	BUY	$5.86 - $7.93 $728,978 - $986,484	124,399 Added 79.32%	281,230 $1.69 Million
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $39,592 - $66,597	6,768 Added 4.51%	156,831 $970,000

Q4 2022 Feb 13, 2023	BUY	$6.88 - $9.55 $772,032 - $1.07 Million	112,214 Added 296.48%	150,063 $1.39 Million
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $35,708 - $57,552	-4,360 Reduced 10.33%	37,849 $358,000
Q2 2022 Aug 11, 2022	SELL	$7.65 - $14.24 $147,935 - $275,373	-19,338 Reduced 31.42%	42,209 $429,000
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $49,124 - $78,402	-3,773 Reduced 5.78%	61,547 $877,000
Q4 2021 Feb 11, 2022	BUY	$19.35 - $25.54 $50,697 - $66,914	2,620 Added 4.18%	65,320 $1.35 Million
Q3 2021 Nov 04, 2021	SELL	$21.65 - $39.49 $1.28 Million - $2.34 Million	-59,337 Reduced 48.62%	62,700 $1.43 Million
Q2 2021 Aug 11, 2021	BUY	$15.5 - $22.48 $1.13 Million - $1.64 Million	72,788 Added 147.8%	122,037 $2.54 Million
Q1 2021 May 13, 2021	SELL	$14.84 - $22.23 $119,165 - $178,506	-8,030 Reduced 14.02%	49,249 $991,000
Q4 2020 Feb 16, 2021	BUY	$9.4 - $16.7 $142,485 - $253,138	15,158 Added 35.99%	57,279 $867,000
Q3 2020 Nov 12, 2020	SELL	$10.54 - $24.96 $48,304 - $114,391	-4,583 Reduced 9.81%	42,121 $444,000
Q2 2020 Aug 13, 2020	SELL	$21.87 - $33.11 $415,070 - $628,394	-18,979 Reduced 28.89%	46,704 $1.14 Million
Q1 2020 May 14, 2020	BUY	$16.25 - $35.28 $886,616 - $1.92 Million	54,561 Added 490.57%	65,683 $1.59 Million
Q4 2019 Feb 14, 2020	BUY	$14.17 - $20.3 $29,005 - $41,554	2,047 Added 22.56%	11,122 $190,000
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $14,967 - $23,043	1,038 Added 12.92%	9,075 $129,000
Q2 2019 Aug 14, 2019	SELL	$16.26 - $26.42 $307,883 - $500,262	-18,935 Reduced 70.2%	8,037 $151,000
Q1 2019 May 15, 2019	BUY	$15.97 - $22.5 $430,742 - $606,870	26,972 New	26,972 $503,000

Others Institutions Holding ALEC

# of Institutions

161

Shares Held

59.8M

Call Options Held

67.8K

Put Options Held

200

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $375M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account